gwp42003-p
Showing 1 - 16 of 16
Seizures Associated With EMAS Trial (GWP42003-P, Placebo)
Recruiting
- Seizures Associated With EMAS
- GWP42003-P
- Placebo
-
Birmingham, Alabama
- +5 more
Jan 30, 2023
Tuberous Sclerosis Complex, Seizures Trial in Boston (GWP42003-P)
Completed
- Tuberous Sclerosis Complex
- Seizures
- GWP42003-P
-
Boston, MassachusettsMassachusetts General Hospital
Jul 12, 2022
Epilepsy Trial in Netherlands, Spain, Sweden (GWP42003-P, Placebo)
Completed
- Epilepsy
- GWP42003-P
- Placebo
-
Zwolle, Netherlands
- +4 more
Dec 19, 2022
Epilepsy Trial in Netherlands, Spain, Sweden (GWP42003-P)
Completed
- Epilepsy
- GWP42003-P
-
Zwolle, Netherlands
- +4 more
Dec 19, 2022
Seizure in Participants With Tuberous Sclerosis Complex Trial in United States (GWP42003-P, SOC)
Recruiting
- Seizure in Participants With Tuberous Sclerosis Complex
- GWP42003-P
- SOC
-
Little Rock, Arkansas
- +3 more
Jul 6, 2022
Autism Spectrum Disorder Trial in Worldwide (GWP42003-P, Placebo)
Recruiting
- Autism Spectrum Disorder
- GWP42003-P
- Placebo
-
Phoenix, Arizona
- +15 more
Jul 28, 2022
Tuberous Sclerosis Complex, Seizures Trial in Worldwide (GWP42003-P, Placebo)
Completed
- Tuberous Sclerosis Complex
- Seizures
- GWP42003-P
- Placebo
-
Birmingham, Alabama
- +43 more
Sep 22, 2022
Rett Syndrome, RTT Trial in Worldwide (GWP42003-P, Placebo)
Terminated
- Rett Syndrome
- RTT
- GWP42003-P
- Placebo
-
Birmingham, Alabama
- +25 more
Dec 1, 2021
Lennox-Gastaut Syndrome Trial (GWP42003-P)
Withdrawn
- Lennox-Gastaut Syndrome
- GWP42003-P
- (no location specified)
Oct 19, 2020
Epilepsy, Dravet Syndrome Trial in Worldwide (GWP42003-P, Placebo Control)
Completed
- Epilepsy
- Dravet Syndrome
- GWP42003-P
- Placebo Control
-
Birmingham, Alabama
- +37 more
Jul 11, 2019
Epilepsy, Lennox Gastaut Syndrome Trial in Worldwide (GWP42003-P, Placebo control)
Completed
- Epilepsy
- Lennox Gastaut Syndrome
- GWP42003-P
- Placebo control
-
Birmingham, Alabama
- +28 more
Jul 26, 2018